Detection of Neck Recurrence in Patients with Differentiated Thyroid Cancer: Comparison of Ultrasound, Contrast-enhanced CT and (18)F-FDG PET/CT Using Surgical Pathology As a Reference Standard: (ultrasound Vs. CT Vs. (18)F-FDG PET/CT In...
Overview
Affiliations
Objectives: To compare the diagnostic performance of ultrasound, contrast-enhanced computed tomography (CT) and (18)F-FDG positron emission tomography (PET)/CT for detecting recurrent differentiated thyroid cancer in the neck.
Methods: Twenty patients who had undergone previous surgery for differentiated thyroid cancer (19 papillary carcinomas; 1 medullary carcinoma) and presented with pathologically proven recurrence in the neck were included. All patients had undergone ultrasound, CT and PET/CT in the 2 months before further surgery. In each patient, ultrasound, CT and PET/CT images were retrospectively reviewed to determine the presence of loco-regional recurrence by level-by-level analysis. Imaging results were correlated with the histological evaluation of the neck dissection as a standard of reference.
Results: Recurrences were found at 52 out of 110 cervical nodal levels surgically explored. The sensitivity, specificity and accuracy were 69.2 %, 89.7 % and 80.0 % for ultrasound; 63.5 %, 94.8 % and 80.0 % for CT; and 53.8 %, 79.3 % and 67.3 % for PET/CT, respectively. ROC analysis revealed higher diagnostic performance with ultrasound than with PET/CT for detecting recurrent tumour.
Conclusions: Although no significant difference was found among the three techniques, the sensitivity and specificity of ultrasound and CT were higher than those of PET/CT for the evaluation of cervical recurrence in patients with differentiated thyroid cancer.
Key Points: • Ultrasound, CT and ( 18 ) F-FDG PET/CT can all detect recurrent thyroid cancer. • Ultrasound and CT have higher sensitivity and specificity. • Ultrasound, CT and ( 18 ) F-FDG PET/CT frequently demonstrated discordant findings.
Roh Y, Chung S, Yang S, Baek J, Choi Y, Sung T Eur Radiol. 2024; 35(1):20-28.
PMID: 38980412 DOI: 10.1007/s00330-024-10919-w.
Chen Y, Zhang Y Arch Med Sci. 2023; 19(4):965-975.
PMID: 37560722 PMC: 10408019. DOI: 10.5114/aoms.2020.95104.
Wang S, Li Q, Tian F, Li J, Li W, Chen M Front Oncol. 2022; 12:990603.
PMID: 36439514 PMC: 9686443. DOI: 10.3389/fonc.2022.990603.
Yang J, Zhang F, Qiao Y BMJ Open. 2022; 12(7):e051568.
PMID: 35788082 PMC: 9255397. DOI: 10.1136/bmjopen-2021-051568.
Song Y, Liu F, Ruan W, Hu F, Younis M, Gao Z Cancers (Basel). 2021; 13(14).
PMID: 34298651 PMC: 8307331. DOI: 10.3390/cancers13143436.